Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iAnthus Capital HoldingsFRA:2IA 14-Day RSI is 48.15 as of Jul. 16, 2026. The stock has 4 warning signs investors should review. Among 1,047 Drug Manufacturers companies, iAnthus Capital Holdings ranks better than 59.98% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for iAnthus Capital Holdings's 14-Day RSI or its related term are showing as below:
FRA:2IA's 14-Day RSI is ranked better than 59.98% of 1047
companies
in the Drug Manufacturers industry
Industry Median: 51.8
vs FRA:2IA: 48.15
iAnthus Capital Holdings (FRA:2IA) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
iAnthus Capital Holdings 14-Day RSI Related Terms
FRA:2IA vs ZTS, UTHR: 14-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iAnthus Capital Holdings 14-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where iAnthus Capital Holdings's 14-Day RSI falls into.
iAnthus Capital Holdings (FRA:2IA) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iAnthus Capital Holdings (FRA:2IA) has a 14-Day RSI of 48.15 as of Jul. 16, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on iAnthus Capital Holdings and its competitors. According to the industry distribution chart, iAnthus Capital Holdings ranks #419 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 40%.
Is iAnthus Capital Holdings' 14-Day RSI too high?
iAnthus Capital Holdings' current 14-Day RSI is 48.15. The Drug Manufacturers industry median 14-Day RSI is 51.80. iAnthus Capital Holdings' value of 48.15 is 7% below this industry median. Based on the distribution chart, iAnthus Capital Holdings ranks #419 out of 1047 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does iAnthus Capital Holdings' 14-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, iAnthus Capital Holdings ranks #419 out of 1047 companies for 14-Day RSI. This puts iAnthus Capital Holdings in the upper half of its industry. The industry median 14-Day RSI is 51.80. iAnthus Capital Holdings' value of 48.15 is 7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Drug Manufacturers company?
The median 14-Day RSI among Drug Manufacturers companies is 51.80, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iAnthus Capital Holdings's current 14-Day RSI of 48.15 is 7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on iAnthus Capital Holdings and its competitors. For the Drug Manufacturers industry, the median 14-Day RSI is 51.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iAnthus Capital Holdings's current 14-Day RSI is 48.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current 14-Day RSI of 48.15. The current 14-Day RSI is 48.15 and 7% below the Drug Manufacturers industry median of 51.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current 14-Day RSI is 48.15 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2IA has been successfully added to your 
